This news item caught my fancy today:
WASHINGTON (Reuters) – A U.S. Food and Drug Administration advisory panel will discuss the safety and effectiveness of over-the-counter cough and cold medicines for children at a meeting in October, the FDA said on Wednesday.
“Questions have been raised about the safety of these products and whether the benefits justify any potential risks from the use of these products in children, especially in children under 2 years of age,” the Food and Drug Administration said in an advisory posted on its Web site.
That would be a shame. It’s hard to calm a sick toddler. Maybe we’ll still be able to procure black-market Baby Benadryl on Continental Express flights.
[tags]Ike Pigott, Occam’s RazR, FDA, medicine[/tags]